An observational study in Pleuritis, sponsored by KU Leuven. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-12-30.
Sponsored by KU Leuven · Observational
Retrospective survey for factors predicting the outcome of medical thoracoscopy
Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis
KU Leuven is the lead sponsor of 358 studies on the registry; 62 are open to participants now.
Counted across the registry records on this site, refreshed daily.
pulmonary or extrathoracic malignancy
Exclusion Criteria:
amelioration of dyspnea radiological amelioration after sterile talc pleurodesis
Drug: sterile talc pleurodesis
unchanged symptoms and radiology after sterile talc pleurodesis
Drug: sterile talc pleurodesis
medical thoracoscopy and talc pleurodesis. No specific device is studied.
Also known as: medical thoracoscopy
Chest X-ray
radiological resolution of pleuritis; 3 level severity grading (A, B, C, with C as worst grade)
Time frame: 3 months
time interval
survival in months
Time frame: 12 months
This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pleurisy
KU Leuven